Australia's Nine Entertainment said that they are aiming to raise US$1.1 billion through an initial public offering.
Investors
Tecnicas Reunidas to win US$1 billion contract
Spanish industrial engineering company, Technicas Reunidas SA announced that they are in the final stages to win a US$1 billion contract for a natural gas processing plant.
Janalakshmi Financial Services close to raising INR300 crore in private equity investments
Sources said that Janalakshmi Financial Services is close to its equity fund raising target of INR300 crore.
Norwegian Cruise Lines investors to sell US$600 million stake
Norwegian Cruise Lines' investors TPG Capital, Apollo Global Management LLC and Genting Hong Kong Ltd are set to sell US$600 million worth of holdings.
Cubist acquires Optimer and Trius for US$1.62 billion
Cubist Pharmaceuticals widens antibiotics portfolio with the Optimer Pharmaceuticals Inc and Trius Therapeutics Inc acquisition.
Latest News
Manchester Airports Group announced plans for a GBP40 million improvement program for London's Stansted Airport.
MVC Capital revealed that it had committed to issuing Biogenic Reagents a senior secured convertible note worth US$9.5 million with a five year maturity.
Mountain Real Estate Capital in a joint venture with DAI/Candlelight Homes announced that they have agreed to purchase and develop the Santorini Village situated in South Jordan, Utah.
Northland Wealth Management revealed the opening of their Calgary, Alberta satellite office. Northland Wealth Management announced that it had opened an satellite office in Calgary, Alberta.
Scotia Private Client Group stated that they have launched Scotia Long Short Equity Fund, a first alternative investment product solution.
Integrated Private Debt Corporation garners US$307 million for its fourth fund. Integrated Private Debt (IPD) Corp. , the private corporate debt unit of Integrated Asset Management Corp.
Apollo Global Management has agreed to pay US$400 million in cash for Pitney Bowes' management services arm.
Cubist Pharmaceuticals said today that it has commenced into a definitive agreement to purchase Trius Therapeutics for USD707 million in cash.
Cubist Pharmaceuticals Inc. and Optimer Pharmaceuticals Inc. announced today that it has signed a merger agreement valued at USD801 million in cash on a fully diluted basis.
